{"id":33628,"date":"2026-02-10T00:01:51","date_gmt":"2026-02-10T00:01:51","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/vascular-endothelial-growth-factors-inhibitors-market-mordor\/"},"modified":"2026-09-11T07:45:52","modified_gmt":"2026-09-10T22:45:52","slug":"vascular-endothelial-growth-factors-inhibitors-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/vascular-endothelial-growth-factors-inhibitors-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ud608\uad00 \ub0b4\ud53c \uc131\uc7a5 \uc778\uc790 (VEGF) \uc5b5\uc81c\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025-2030\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/vascular-endothelial-growth-factors-inhibitors-market-1715165180651-Key-Players-Chart-Template.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/vascular-endothelial-growth-factors-inhibitors-market-size-image-1735473357608.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \uc5ed\ud559<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc784\uc0c1 \ud30c\uc774\ud504\ub77c\uc778 \ubd84\uc11d\uc758 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.3 \ubcd1\uc6a9 \uc694\ubc95\uc758 \uc778\uae30 \uc99d\uac00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc720\uc804\uc790 \uce58\ub8cc\uc5d0 \ub300\ud55c \uc120\ud638\ub3c4 \uc99d\uac00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \ud3ec\ud130\uc758 5\uac00\uc9c0 \ud798 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.4.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.2 \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uc138\ubd84\ud654 (\uac00\uce58 \uae30\uc900 \uc2dc\uc7a5 \uaddc\ubaa8 &#8211; USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 VEGF-A<\/li>\n<li class=\"toc-level-3\">5.1.2 VEGF-B<\/li>\n<li class=\"toc-level-3\">5.1.3 VEGF-C<\/li>\n<li class=\"toc-level-3\">5.1.4 VEGF-D<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc548\uacfc\ud559<\/li>\n<li class=\"toc-level-3\">5.2.3 \uae30\ud0c0 \uc801\uc6a9 \ubd84\uc57c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc815\ub9e5 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.3.2 \uacbd\uad6c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubcd1\uc6d0<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<li class=\"toc-level-3\">5.4.3 \uae30\ud0c0 \ucd5c\uc885 \uc0ac\uc6a9\uc790<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \ud68c\uc0ac \ud504\ub85c\ud544\n<ul>\n<li class=\"toc-level-3\">6.1.1 F. \ud638\ud504\ub9cc-\ub77c \ub85c\uc288 \uc8fc\uc2dd\ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">6.1.2 \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74<\/li>\n<li class=\"toc-level-3\">6.1.3 \ud14c\ubc14 \uc81c\uc57d \uc0b0\uc5c5 \uc8fc\uc2dd\ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">6.1.4 F. \ud638\ud504\ub9cc-\ub77c \ub85c\uc288 \uc8fc\uc2dd\ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">6.1.5 \ub9ac\uc81c\ub124\ub860 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4 \uc8fc\uc2dd\ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">6.1.6 \ubc14\uc774\uc5d8 AG<\/li>\n<li class=\"toc-level-3\">6.1.7 \ub178\ubc14\ud2f0\uc2a4 AG<\/li>\n<li class=\"toc-level-3\">6.1.8 \uba38\ud06c KGaA<\/li>\n<li class=\"toc-level-3\">6.1.9 \ud654\uc774\uc790 \uc8fc\uc2dd\ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">6.1.10 \uc5d1\uc2a4\ube0c\ub808\uc778 \ubc14\uc774\uc624\ud30c\ub9c8 AB<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\ubaa9\ub85d\uc740 \uc804\uccb4\uac00 \uc544\ub2d8<\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \ub3d9\ud5a5<\/p>\n<div style=\"font-family:regular_semibold\">\uc774\uc6a9 \uac00\ub2a5 \uc5ec\ubd80\uc5d0 \ub530\ub984<\/div>\n<div style=\"font-family:regular_semibold\">\uacbd\uc7c1 \ud658\uacbd\uc740 \ub2e4\uc74c\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4: \uc0ac\uc5c5 \uac1c\uc694, \uc7ac\ubb34, \uc81c\ud488 \ubc0f \uc804\ub7b5, \uadf8\ub9ac\uace0 \ucd5c\uadfc \ub3d9\ud5a5<\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud608\uad00 \ub0b4\ud53c \uc131\uc7a5 \uc778\uc790(VEGF) \uc5b5\uc81c\uc81c \uc2dc\uc7a5 \ubcf4\uace0\uc11c\ub294 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc131\uc7a5, \ub3d9\ud5a5 \ubc0f \uc608\uce21\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8e8\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 VEGF \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc744 \uc720\ud615\ubcc4(VEGF-A, VEGF-B, VEGF-C, VEGF-D), \uc801\uc6a9 \ubd84\uc57c\ubcc4(\uc885\uc591\ud559, \uc548\uacfc, \uae30\ud0c0), \ud22c\uc5ec \uacbd\ub85c\ubcc4(\uc815\ub9e5 \uc8fc\uc0ac, \uacbd\uad6c), \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4(\ubcd1\uc6d0, \uc804\ubb38 \ud074\ub9ac\ub2c9, \uae30\ud0c0) \ubc0f \uc9c0\uc5ed\ubcc4(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ub85c \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc804\ub9dd<br \/>\nMordor Intelligence\uc758 \ubd84\uc11d\uc5d0 \ub530\ub974\uba74, \ud608\uad00 \ub0b4\ud53c \uc131\uc7a5 \uc778\uc790(VEGF) \uc5b5\uc81c\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\ub294 2025\ub144\uc5d0 146\uc5b5 \ub2ec\ub7ec\ub85c \ucd94\uc815\ub418\uba70, 2030\ub144\uc5d0\ub294 193\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc740 5.8%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c, \ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p>VEGF \uc5b5\uc81c\uc81c \uac1c\uc694 \ubc0f \uc791\uc6a9 \uae30\uc804<br \/>\nVEGF \uc5b5\uc81c\uc81c\ub294 \ud608\uad00 \ub0b4\ud53c \uc131\uc7a5 \uc778\uc790(VEGF)\uc640 \uadf8 \uc218\uc6a9\uccb4(VEGFR)\uc758 \ud65c\ub3d9\uc744 \ubc29\ud574\ud558\ub294 \uc57d\ubb3c\uc785\ub2c8\ub2e4. \uc774 \ubd84\uc790\ub4e4\uc740 \ud608\uad00\uc2e0\uc0dd(angiogenesis), \uc989 \uc0c8\ub85c\uc6b4 \ud608\uad00 \ud615\uc131\uc5d0 \ud544\uc218\uc801\uc778 \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. VEGF \uc5b5\uc81c\uc81c \uc57d\ubb3c\uc740 \ud608\uad00 \ub204\ucd9c\uc744 \uc904\uc774\uace0 \ube44\uc815\uc0c1\uc801\uc778 \ud608\uad00 \uc131\uc7a5\uc744 \uc5b5\uc81c\ud569\ub2c8\ub2e4. \ub208\uc5d0\uc11c \ubc1c\uc0dd\ud558\ub294 \uc774\ub7ec\ud55c \ube44\uc815\uc0c1\uc801\uc778 \ud608\uad00 \uc131\uc7a5\uc740 \uc2dc\ub825 \uc800\ud558 \ub610\ub294 \uc2e4\uba85\uc744 \uc720\ubc1c\ud558\uba70 \ub208\uc5d0 \uc190\uc0c1\uc744 \uc785\ud790 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ud56d-VEGF \uc57d\ubb3c\uc740 VEGF\ub97c \ucc28\ub2e8\ud558\uc5ec \ud608\uad00 \uc131\uc7a5\uc744 \ubc29\ud574\ud558\uace0 \ub208\uc758 \uc2dc\ub825\uc744 \uac1c\uc120\ud558\ub294 \ub370 \ub3c4\uc6c0\uc744 \uc90d\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778<br \/>\n1. \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(AMD) \uc720\ubcd1\ub960 \uc99d\uac00:<br \/>\nCureus Journal\uc758 2022\ub144 9\uc6d4 \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74, \uc120\uc9c4\uad6d\uc5d0\uc11c 60\uc138 \uc774\uc0c1 \uc778\uad6c\uc758 \uc57d 8\uba85 \uc911 1\uba85\uc774 \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(AMD)\uc758 \uc601\ud5a5\uc744 \ubc1b\uc2b5\ub2c8\ub2e4. \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc57d 2\uc5b5 \uba85\uc758 \uc0ac\ub78c\ub4e4\uc774 AMD\ub97c \uc553\uace0 \uc788\ub294 \uac83\uc73c\ub85c \ucd94\uc815\ub418\uba70, 2040\ub144\uae4c\uc9c0 \uadf8 \uc720\ubcd1\ub960\uc740 \uac70\uc758 3\uc5b5 \uba85\uc73c\ub85c \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. AMD\ub294 \ub208\uc758 \ud669\ubc18 \uc544\ub798\uc5d0 \ube44\uc815\uc0c1\uc801\uc778 \ud608\uad00\uc774 \ud615\uc131\ub418\uc5b4 \ubc1c\uc0dd\ud558\ub294 \uc9c8\ud658\uc73c\ub85c, \uc774 \ud608\uad00\uc5d0\uc11c \uccb4\uc561\uc774 \ub204\ucd9c\ub418\uc5b4 \ub9dd\ub9c9\uc758 \uc815\uc0c1\uc801\uc778 \uad6c\uc870\ub97c \uc190\uc0c1\uc2dc\ud0a4\uace0 \ud669\ubc18\uc5d0 \uc190\uc0c1\uc744 \uc785\ud799\ub2c8\ub2e4. \ucd08\uae30 \uc99d\uc0c1\uc73c\ub85c\ub294 \uc2dc\uc57c \uc65c\uace1(\ubcc0\ud615\uc2dc\uc99d)\uacfc \uc0ac\ubb3c \uc778\uc9c0 \uc5b4\ub824\uc6c0\uc774 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n\uc774\ucc98\ub7fc \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(AMD)\uc758 \uc720\ubcd1\ub960\uc774 \uc99d\uac00\ud558\uace0, \ud56d-VEGF \uc57d\ubb3c\uc774 \ud6a8\uacfc\uc801\uc778 \uce58\ub8cc \uc635\uc158\uc73c\ub85c \uc790\ub9ac\ub9e4\uae40\ud558\uba74\uc11c VEGF \uc5b5\uc81c\uc81c \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \ud06c\uac8c \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uad11\ubc94\uc704\ud558\uace0 \uc99d\uac00\ud558\ub294 \ud658\uc790\uad70\uc740 \uc2dc\ub825\uc744 \ubcf4\uc874\ud558\uae30 \uc704\ud55c \ud6a8\uacfc\uc801\uc778 \uce58\ub8cc\ubc95\uc744 \ucc3e\uace0 \uc788\uc5b4 \ud56d-VEGF \uce58\ub8cc\uc5d0 \ub300\ud55c \uc0c1\ub2f9\ud55c \uc218\uc694\ub97c \ucc3d\ucd9c\ud558\uba70 \uc2dc\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2. \uc554 \uc720\ubcd1\ub960 \uc99d\uac00:<br \/>\n\uc138\uacc4\ubcf4\uac74\uae30\uad6c(WHO)\uc5d0 \ub530\ub974\uba74, 2022\ub144 \uc804 \uc138\uacc4 \uc554 \ubd80\ub2f4\uc740 2\ucc9c\ub9cc \uac74\uc758 \uc2e0\uaddc \uc0ac\ub840\uc640 970\ub9cc \uba85\uc758 \uc0ac\ub9dd\uc790\ub85c \ucd94\uc815\ub429\ub2c8\ub2e4. \ud3c9\uc0dd \ub3d9\uc548 \uc57d 5\uba85 \uc911 1\uba85\uc774 \uc554\uc5d0 \uac78\ub9ac\uba70, \ub0a8\uc131 \uc57d 9\uba85 \uc911 1\uba85, \uc5ec\uc131 \uc57d 12\uba85 \uc911 1\uba85\uc774 \uc554\uc73c\ub85c \uc0ac\ub9dd\ud569\ub2c8\ub2e4. 2050\ub144\uc5d0\ub294 \uc2e0\uaddc \uc554 \ud658\uc790 \uc218\uac00 3,500\ub9cc \uba85\uc744 \ub118\uc5b4\uc124 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\ub294\ub370, \uc774\ub294 2022\ub144 \ucd94\uc815\uce58\uc778 2\ucc9c\ub9cc \uba85\uc5d0\uc11c 77% \uc99d\uac00\ud55c \uc218\uce58\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc804 \uc138\uacc4\uc801\uc778 \uc554 \ubd80\ub2f4\uc758 \uae09\uaca9\ud55c \uc99d\uac00\ub294 \uc778\uad6c \uace0\ub839\ud654 \ubc0f \uc99d\uac00\uc640 \ub354\ubd88\uc5b4 \uc704\ud5d8 \uc694\uc778 \ub178\ucd9c \ubcc0\ud654\uc758 \uacb0\uacfc\uc785\ub2c8\ub2e4.<br \/>\n\uc774\ucc98\ub7fc \ub9ce\uc740 \uc218\uc758 \ud658\uc790\ub294 \ud6a8\uacfc\uc801\uc778 \uce58\ub8cc \uc635\uc158\uc5d0 \ub300\ud55c \ud544\uc694\uc131\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4. VEGF\ub294 \uc885\uc591\uc758 \uc131\uc7a5\uacfc \ud655\uc0b0\uc5d0 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. \uc554\uc138\ud3ec\ub294 VEGF \uc2e0\ud638\ub97c \uc774\uc6a9\ud558\uc5ec \uc0c8\ub85c\uc6b4 \ud608\uad00\uc744 \ud615\uc131\ud558\uba70, \uc774 \uc0c8\ub85c\uc6b4 \ud608\uad00\uc740 \uc554\uc138\ud3ec\uc5d0 \uc0b0\uc18c\uc640 \uc601\uc591\ubd84\uc744 \uacf5\uae09\ud558\uc5ec \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \ud655\uc0b0\ub418\ub3c4\ub85d \ud569\ub2c8\ub2e4. VEGF \uc5b5\uc81c\uc81c\ub294 \uc774 \uacfc\uc815\uc744 \ubc29\ud574\ud558\uc5ec \uc885\uc591\uc758 \uc601\uc591\ubd84 \uacf5\uae09\uc744 \ucc28\ub2e8\ud558\uace0 \uc131\uc7a5\uc744 \ub2a6\ucda5\ub2c8\ub2e4.<br \/>\nJournal of Hematology &#038; Oncology(2022)\uc5d0 \ubc1c\ud45c\ub41c \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74, VEGF \uc5b5\uc81c\uc81c\ub294 \ub2e4\uc591\ud55c \uc554 \uce58\ub8cc\uc5d0\uc11c \uc131\uacf5\uc801\uc778 \uc2e4\uc801\uc744 \ubcf4\uc5ec\uc654\uc2b5\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, VEGF \ud45c\uc801 \uc57d\ubb3c\uc778 \uc544\ubc14\uc2a4\ud2f4(Avastin)\uc740 \ud3d0\uc554, \ub300\uc7a5\uc554 \ubc0f \uae30\ud0c0 \uc720\ud615\uc758 \uc554 \uce58\ub8cc\uc5d0 \ud6a8\uacfc\uc801\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc57d\ubb3c\ub4e4\uc740 \uc554 \uce58\ub8cc\uc758 \ucd08\uc11d\uc73c\ub85c \ud655\uace0\ud788 \uc790\ub9ac \uc7a1\uc558\uc2b5\ub2c8\ub2e4. \ub530\ub77c\uc11c \uc554 \uc720\ubcd1\ub960 \uc99d\uac00\ub294 VEGF \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc744 \uacac\uc778\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \uc81c\uc57d \uc694\uc778<br \/>\n\uadf8\ub7ec\ub098 VEGF \uc5b5\uc81c\uc81c \uc0ac\uc6a9\uacfc \uad00\ub828\ub41c \ubd80\uc791\uc6a9\uacfc \uc720\uc804\uc790 \uce58\ub8cc\uc5d0 \ub300\ud55c \uc120\ud638\ub3c4 \uc99d\uac00\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<br \/>\n1. \uc751\uc6a9 \ubd84\uc57c\ubcc4 \ub3d9\ud5a5 &#8211; \uc885\uc591\ud559 \ubd80\ubb38:<br \/>\n\uc885\uc591\ud559 \uc751\uc6a9 \ubd84\uc57c\ub294 VEGF \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc73c\uba70, \ud5a5\ud6c4 5\ub144\uac04 \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc804 \uc138\uacc4\uc801\uc778 \uc554 \ubd80\ub2f4\uc758 \uae09\uc99d\uc740 \ud6a8\uacfc\uc801\uc778 \uce58\ub8cc \uc635\uc158\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ud0a4\uba70, VEGF \uc5b5\uc81c\uc81c\uac00 \uc885\uc591\uc758 \uc131\uc7a5\uacfc \ud655\uc0b0\uc744 \uc5b5\uc81c\ud558\ub294 \ub370 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud558\ubbc0\ub85c \uc774 \ubd80\ubb38\uc758 \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>2. \uc9c0\uc5ed\ubcc4 \ub3d9\ud5a5 &#8211; \ubd81\ubbf8 \uc2dc\uc7a5:<br \/>\n\ubd81\ubbf8 \uc9c0\uc5ed\uc740 VEGF \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc5d0\uc11c \uc120\ub450\ub97c \ub2ec\ub9ac\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc8fc\ub85c \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(AMD)\uc758 \ub192\uc740 \uc720\ubcd1\ub960, \ube60\ub974\uac8c \uc99d\uac00\ud558\ub294 \uace0\ub839\ud654 \uc778\uad6c, \uadf8\ub9ac\uace0 \uc784\uc0c1 \ud30c\uc774\ud504\ub77c\uc778\uc758 \ubc1c\uc804\uc774 \uc774 \uc9c0\uc5ed \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud560 \uac83\uc774\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4.<br \/>\n\ubd81\ubbf8\ub294 \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(AMD)\uc758 \uc720\ubcd1\ub960\uc774 \ub192\uc73c\uba70, \uc2b5\uc131 \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(wet-AMD)\uc740 \ub178\ub144\uce35\uc5d0\uc11c \uc2ec\uac01\ud55c \uc2dc\ub825 \uc0c1\uc2e4\uc758 \uc8fc\uc694 \uc6d0\uc778\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ub9ce\uc740 \ud658\uc790\ub4e4\uc740 VEGF \uc5b5\uc81c\uc81c\uc640 \uac19\uc740 \ud6a8\uacfc\uc801\uc778 \uce58\ub8cc\ubc95\uc744 \ud544\uc694\ub85c \ud569\ub2c8\ub2e4. AMD\ub294 \ub178\ud654\uc640 \uad00\ub828\ub41c \uc9c8\ubcd1\uc774\uba70, \ubd81\ubbf8\uc758 \uace0\ub839\ud654 \uc778\uad6c\ub294 AMD \uc0ac\ub840 \uc99d\uac00\uc5d0 \uae30\uc5ec\ud569\ub2c8\ub2e4. \uc778\uad6c\uac00 \uace0\ub839\ud654\ub428\uc5d0 \ub530\ub77c AMD \uc0ac\ub840\ub294 \uacc4\uc18d \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\nMacular Degeneration Research\uc758 2023\ub144 2\uc6d4 \ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \ud669\ubc18\ubcc0\uc131\uc740 \ub3cc\uc774\ud0ac \uc218 \uc5c6\ub294 \uc2e4\uba85 \ubc0f \uc2dc\ub825 \uc190\uc0c1\uc758 \uc8fc\uc694 \uc6d0\uc778 \uc911 \ud558\ub098\uc785\ub2c8\ub2e4. \ubbf8\uad6d\uc5d0\uc11c\ub294 \uc57d 2\ucc9c\ub9cc \uba85\uc758 \uc131\uc778\uc774 \uc5b4\ub5a4 \ud615\ud0dc\ub85c\ub4e0 AMD\ub97c \uc553\uace0 \uc788\uc73c\uba70, 150\ub9cc \uba85\uc740 \uc9c4\ud589\uc131 \ud615\ud0dc\ub97c \uc553\uace0 \uc788\uc2b5\ub2c8\ub2e4. National Eye Institute(2023)\uc758 \uc0c8\ub85c\uc6b4 \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74, AMD\ub97c \uc553\uace0 \uc788\ub294 \uc0ac\ub78c\ub4e4\uc758 \uc218\ub294 2010\ub144\uc5d0\uc11c 2050\ub144 \uc0ac\uc774\uc5d0 210\ub9cc \uba85\uc5d0\uc11c 540\ub9cc \uba85\uc73c\ub85c \ub450 \ubc30 \uc774\uc0c1 \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ub610\ud55c, \uc9c4\ub2e8 \uae30\uc220\uc758 \ubc1c\uc804\uc73c\ub85c AMD\ub97c \ub354 \uc77c\ucc0d \uc9c4\ub2e8\ud560 \uc218 \uc788\uac8c \ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc870\uae30 \uc9c4\ub2e8\uc740 \uc2dc\ub825 \uc190\uc2e4\uc744 \uc608\ubc29\ud558\ub294 \ub370 \ub3c4\uc6c0\uc774 \ub418\ub294 \ud56d-VEGF \uc5b5\uc81c\uc81c\ub85c \uc2e0\uc18d\ud558\uac8c \uce58\ub8cc\ud560 \uc218 \uc788\ub3c4\ub85d \ud569\ub2c8\ub2e4.<br \/>\n\uce90\ub098\ub2e4\uc5d0\uc11c\ub3c4 \ud56d-VEGF \uc5b5\uc81c\uc81c\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uae09\uc99d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131\uc758 \ub192\uc740 \ubc1c\uc0dd\ub960\uc740 \uce58\ub8cc \uc218\uc694\ub97c \uc7a0\uc7ac\uc801\uc73c\ub85c \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Investigative Ophthalmology &#038; Visual Science\uc758 2022\ub144 6\uc6d4 \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74, \uce90\ub098\ub2e4\uc778\uc758 \uc57d 2.5%\uac00 \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(AMD)\uc744 \uc553\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n\uacb0\ub860\uc801\uc73c\ub85c, \uace0\ub839\ud654 \uc778\uad6c, \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(AMD) \uc720\ubcd1\ub960 \uc99d\uac00, \uc758\ub8cc\ube44 \uc9c0\ucd9c \uc99d\uac00, \uc9c8\ubcd1 \uc778\uc2dd \ud5a5\uc0c1, \uadf8\ub9ac\uace0 \uacac\uace0\ud55c \uac1c\ubc1c \ud30c\uc774\ud504\ub77c\uc778\uc758 \uacb0\ud569\uc740 \ubd81\ubbf8 \uc9c0\uc5ed\uc5d0\uc11c VEGF \uc5b5\uc81c\uc81c\uc5d0 \ub300\ud55c \uc218\uc694 \uae09\uc99d\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<br \/>\nVEGF \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc740 \ub9e4\uc6b0 \uacbd\uc7c1\uc774 \uce58\uc5f4\ud558\uba70, \uae30\uc874 \uae30\uc5c5\uacfc \uc2e0\uaddc \uc9c4\uc785\uc790\ub4e4\uc774 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ub193\uace0 \uacbd\uc7c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud601\uc2e0, \ud2b9\ud5c8 \ub9cc\ub8cc, \uadf8\ub9ac\uace0 \ubbf8\ucda9\uc871 \uc218\uc694\uac00 \uc774 \uc2dc\uc7a5\uc758 \ubbf8\ub798\ub97c \ud615\uc131\ud558\ub294 \ud575\uc2ec \ub3d9\uc778\uc785\ub2c8\ub2e4. \uc2dc\uc7a5\uc758 \uc8fc\uc694 \ucc38\uc5ec \uae30\uc5c5\uc73c\ub85c\ub294 F. Hoffmann-La Roche Ltd, AstraZeneca, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc., Bayer AG, Novartis AG, Merck KGaA, Pfizer Inc., Xbrane Biopharma AB \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ubc1c\uc804<br \/>\n*   2023\ub144 8\uc6d4: Regeneron Pharmaceuticals\ub294 \uc2b5\uc131 \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(wAMD), \ub2f9\ub1e8\ubcd1\uc131 \ud669\ubc18 \ubd80\uc885(DME), \ub2f9\ub1e8\ubcd1\uc131 \ub9dd\ub9c9\ubcd1\uc99d(DR) \uce58\ub8cc\ub97c \uc704\ud55c EYLEA HD (aflibercept) \uc8fc\uc0ac 8mg\uc5d0 \ub300\ud574 FDA \uc2b9\uc778\uc744 \ud68d\ub4dd\ud588\uc2b5\ub2c8\ub2e4. EYLEA HD\ub294 \ucd08\uae30 \uce58\ub8cc \ub2e8\uacc4 \uc774\ud6c4 \ud45c\uc900 EYLEA\uc5d0 \ube44\ud574 \ud22c\uc5ec \uac04\uaca9\uc744 \uc5f0\uc7a5\ud560 \uc218 \uc788\ub294 \uc7a0\uc7ac\uc801\uc778 \uc774\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   2023\ub144 5\uc6d4: STADA\uc640 Xbrane\uc740 \ub3c5\uc77c\uc5d0\uc11c \ucd5c\ucd08\uc758 \ub77c\ub2c8\ube44\uc8fc\ub9d9 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc778 Ximluci\u00ae\ub97c \uacf5\ub3d9 \ucd9c\uc2dc\ud588\uc2b5\ub2c8\ub2e4. Ximluci\ub294 \ub9dd\ub9c9\uc758 \uc2e0\uc0dd\ud608\uad00 \uc9c8\ud658(nAMD, DME, PDR, RVO, CNV)\uc744 \ud45c\uc801\uc73c\ub85c \ud569\ub2c8\ub2e4. \uc774 \ucd9c\uc2dc\ub294 STADA\uc758 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c 6\uac1c \uc81c\ud488\uc73c\ub85c \ud655\uc7a5\ud558\uace0 \ub3c5\uc77c \uc548\uacfc \uc758\uc0ac\ub4e4\uc5d0\uac8c \uc0c8\ub85c\uc6b4 \uce58\ub8cc \uc635\uc158\uc744 \uc81c\uacf5\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2022\ub144 8\uc6d4: Teva Pharmaceutical Industries Ltd\ub294 \uc720\ub7fd \uc704\uc6d0\ud68c(EC)\uac00 \uc548\uacfc \uce58\ub8cc\uc81c Lucentis\uc758 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc778 Ranivisio (ranibizumab)\uc5d0 \ub300\ud574 Lucentis\uac00 \uc2b9\uc778\ub41c \uc131\uc778 5\uac00\uc9c0 \uc801\uc751\uc99d \ubaa8\ub450\uc5d0 \ub300\ud55c \ud310\ub9e4 \ud5c8\uac00\ub97c \ubd80\uc5ec\ud588\ub2e4\uace0 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacb0\ub860<br \/>\nVEGF \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc740 \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131 \ubc0f \uc554\uacfc \uac19\uc740 \uc8fc\uc694 \uc9c8\ubcd1\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 \uacac\uace0\ud55c \uc131\uc7a5\uc744 \uc9c0\uc18d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud2b9\ud788 \ubd81\ubbf8 \uc9c0\uc5ed\uacfc \uc885\uc591\ud559 \ubd84\uc57c\uac00 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud560 \uac83\uc774\uba70, \ud65c\ubc1c\ud55c \uc5f0\uad6c \uac1c\ubc1c\uacfc \uc2e0\uc81c\ud488 \ucd9c\uc2dc\uac00 \uc2dc\uc7a5 \uacbd\uc7c1\uc744 \uc2ec\ud654\uc2dc\ud0a4\uace0 \ud601\uc2e0\uc744 \ucd09\uc9c4\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \ud608\uad00 \ub0b4\ud53c \uc131\uc7a5 \uc778\uc790(VEGF) \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uacfc \ubbf8\ub798 \uc804\ub9dd\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. VEGF \uc5b5\uc81c\uc81c\ub294 \uae30\uc874 \ud608\uad00\uc5d0\uc11c \uc0c8\ub85c\uc6b4 \ud608\uad00\uc744 \uc0dd\uc131\ud558\ub294 \uacfc\uc815\uc778 \ud608\uad00\uc2e0\uc0dd\uc744 \uc870\uc808\ud558\ub294 \ud608\uad00 \ub0b4\ud53c \uc131\uc7a5 \uc778\uc790 \uc218\uc6a9\uccb4(VEGFR) \uc2e0\ud638 \uc804\ub2ec\uc744 \uc5b5\uc81c\ud558\ub294 \ubb3c\uc9c8\ub85c \uc815\uc758\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8\ub294 2024\ub144 137.5\uc5b5 \ub2ec\ub7ec\ub85c \ucd94\uc815\ub418\uc5c8\uc73c\uba70, 2025\ub144\uc5d0\ub294 146\uc5b5 \ub2ec\ub7ec\uc5d0 \ub3c4\ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ud6c4 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 5.80%\uc758 \uacac\uace0\ud55c \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uba70 2030\ub144\uc5d0\ub294 193.5\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc8fc\uc694 \uc131\uc7a5 \ub3d9\uc778\uc73c\ub85c\ub294 \uc784\uc0c1 \ud30c\uc774\ud504\ub77c\uc778 \ubd84\uc11d \uae30\uc220\uc758 \ubc1c\uc804, \uc5f0\ub839 \uad00\ub828 \ud669\ubc18\ubcc0\uc131(AMD) \uc720\ubcd1\ub960\uc758 \uc9c0\uc18d\uc801\uc778 \uc99d\uac00, \uadf8\ub9ac\uace0 \ub2e4\uc591\ud55c \uc9c8\ud658 \uce58\ub8cc\uc5d0 \uc788\uc5b4 \ubcd1\uc6a9 \uc694\ubc95\uc758 \uc778\uae30\uac00 \ub192\uc544\uc9c0\ub294 \ucd94\uc138 \ub4f1\uc774 \uaf3d\ud799\ub2c8\ub2e4. \ubc18\uba74, \uc720\uc804\uc790 \uce58\ub8cc\uc5d0 \ub300\ud55c \uc120\ud638\ub3c4\uac00 \uc810\ucc28 \uc99d\uac00\ud558\ub294 \uacbd\ud5a5\uc740 VEGF \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uc77c\ubd80 \uc81c\uc57d\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \ub610\ud55c \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d(\uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825, \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825, \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4)\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \uacbd\uc7c1 \ud658\uacbd\uacfc \uad6c\uc870\ub97c \uc2ec\uce35\uc801\uc73c\ub85c \ud3c9\uac00\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654\ub294 \uc5ec\ub7ec \uae30\uc900\uc5d0 \ub530\ub77c \uc774\ub8e8\uc5b4\uc9d1\ub2c8\ub2e4. \uc720\ud615\ubcc4\ub85c\ub294 VEGF-A, VEGF-B, VEGF-C, VEGF-D\ub85c \uad6c\ubd84\ub418\uba70, \uc801\uc6a9 \ubd84\uc57c\ubcc4\ub85c\ub294 \uc885\uc591\ud559, \uc548\uacfc\ud559, \uadf8\ub9ac\uace0 \uad00\uc808\uc5fc \ubc0f \uc2ec\ud608\uad00 \uc9c8\ud658 \ub4f1\uc744 \ud3ec\ud568\ud558\ub294 \uae30\ud0c0 \uc801\uc6a9 \ubd84\uc57c\ub85c \ub098\ub269\ub2c8\ub2e4. \ud22c\uc5ec \uacbd\ub85c\uc5d0 \ub530\ub77c\uc11c\ub294 \uc815\ub9e5 \uc8fc\uc0ac \ubc29\uc2dd\uacfc \uacbd\uad6c \ud22c\uc5ec \ubc29\uc2dd\uc73c\ub85c \ubd84\ub958\ub418\uba70, \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\ub85c\ub294 \ubcd1\uc6d0, \uc804\ubb38 \ud074\ub9ac\ub2c9, \uadf8\ub9ac\uace0 \uc678\ub798 \uc218\uc220 \uc13c\ud130 \ubc0f \uc7ac\ud0dd \uce58\ub8cc \ud658\uacbd \ub4f1\uc744 \ud3ec\ud568\ud558\ub294 \uae30\ud0c0 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\ub9ac\uc801 \uc138\ubd84\ud654\ub294 \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ubc0f \uae30\ud0c0 \uc720\ub7fd), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud638\uc8fc, \ud55c\uad6d \ubc0f \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74(GCC, \ub0a8\uc544\ud504\ub9ac\uce74 \ubc0f \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74), \ub0a8\ubbf8(\ube0c\ub77c\uc9c8, \uc544\ub974\ud5e8\ud2f0\ub098 \ubc0f \uae30\ud0c0 \ub0a8\ubbf8)\ub85c \uc774\ub8e8\uc5b4\uc838 \uc788\uc73c\uba70, \uac01 \uc9c0\uc5ed \ub0b4 \ucd1d 17\uac1c \uad6d\uac00\uc5d0 \ub300\ud55c \uc0c1\uc138\ud55c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc608\uce21 \ub370\uc774\ud130\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4 \ubd84\uc11d \uacb0\uacfc, 2025\ub144\uc5d0\ub294 \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubc18\uba74, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc608\uce21 \uae30\uac04\uc778 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0 \uac00\uc7a5 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uba70 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uc5b4, \ud5a5\ud6c4 \uc2dc\uc7a5 \uc131\uc7a5\uc758 \ud575\uc2ec \ub3d9\ub825\uc774 \ub420 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5\uc73c\ub85c\ub294 F. Hoffmann-La Roche Ltd, Astrazeneca, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc., Bayer AG, Novartis AG, Merck KGaA, Pfizer Inc., Xbrane Biopharma AB \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\uace0\uc11c\uc758 \uacbd\uc7c1 \ud658\uacbd \uc139\uc158\uc5d0\uc11c\ub294 \uc774\ub4e4 \uae30\uc5c5\uc758 \ube44\uc988\ub2c8\uc2a4 \uac1c\uc694, \uc7ac\ubb34 \uc131\uacfc, \uc81c\ud488 \ubc0f \uc804\ub7b5, \uadf8\ub9ac\uace0 \ucd5c\uadfc \uac1c\ubc1c \ub3d9\ud5a5\uc5d0 \ub300\ud55c \uc0c1\uc138\ud55c \uc815\ubcf4\ub97c \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 2019\ub144\ubd80\ud130 2024\ub144\uae4c\uc9c0\uc758 \uacfc\uac70 \uc2dc\uc7a5 \uaddc\ubaa8 \ub370\uc774\ud130\uc640 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \ubbf8\ub798 \uc2dc\uc7a5 \uaddc\ubaa8 \uc608\uce21\uc744 \ud3ec\ud568\ud558\uc5ec, \ud608\uad00 \ub0b4\ud53c \uc131\uc7a5 \uc778\uc790 \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \ud750\ub984\uacfc \uc8fc\uc694 \ub3d9\ud5a5\uc744 \uc774\ud574\ud558\uace0 \uc804\ub7b5\uc801 \uc758\uc0ac\uacb0\uc815\uc744 \ub0b4\ub9ac\ub294 \ub370 \ud544\uc218\uc801\uc778 \uc815\ubcf4\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-33628","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/33628"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=33628"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/33628\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=33628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=33628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=33628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}